Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » Medicine » Immune Disorders » Autoimmune Disorders: Symptoms, Diagnosis and Treatment Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Public Health Yearbook 2013
$310.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266
Tell A Friend
 
Tell someone you know about this product.
Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266 $100.00
Authors:  (E.W. Brenu, L. Tajouri, D.R. Staines, S. Marshall-Gradisnik, Faculty of Health Science and Medicine, Population Health and Neuroimmunology Unit, Bond University, Robina, Queensland, Australia, and others)
Abstract:
Immunomodulation and immunosuppression are important strategies for monitoring autoimmune disorders. As imbalances in immune function affect other physiological processes, immunomodulators may have an important role in restoring and maintaining regular neuroimmue activities. In recent years these agents have demonstrated important benefits in controlling the mechanisms associated with deteriorating central nervous system pathologies such as Multiple Sclerosis (MS), where central and peripheral nervous system immune regulation is impaired. MS is characterized by severe compromises to neuroimmune processes involving changes in immune cell function, soluble proteins and modulation of inflammatory processes. The introduction of therapeutic agents in the form of immunomodulators; interferon, phosphodiesterase inhibitors and Glatiramer acetate have proven to be useful to some extent in reducing the severity of MS. Herein the implications and effects of these molecules on the immune system in MS are reviewed. Additionally, the available evidence on the mode of action of neuropeptides in MS, their effectiveness on clinical measures, and current knowledge are also reviewed. 


Available Options:
Version:
Special Focus Titles
01.Mountains: Geology, Topography and Environmental Concerns
02.A Short History of the Georgian Church
03.Private Investigations: Suspicion of Financial Crime by White-Collar Criminals
04.Cellular and Molecular Mechanisms of Honey Wound Healing
05.Controversies in Preeclampsia
06.Bioengineering Nursing: New Horizons of Nursing Research
07.Innovation and Global Competition: The Case of Korea
08.Network-Based Continuing Medical Education: Social Media and Professional Development
09.Fractional Calculus in Analysis, Dynamics and Optimal Control
10.The Infinite History of NOW: A Timeless Background for Contemporary Physics
11.Borderline Personality Disorder: Understanding the Unconscious Function of Deliberate Self Harm and Managing the Transference Relationship
12.Energy and Environment Nowadays

Nova Science Publishers
© Copyright 2004 - 2014

Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266